Dr. Ron Gladue

Accomplished pharmaceutical scientific and strategic leader with over 34 years of experience in drug discovery and development for immunological diseases (immune-oncology, autoimmunity, antibody-based therapies for infectious disease). Lead over 14 drug discovery programs and co-inventor on 13 patents. Involved with numerous strategic initiatives receiving awards for innovation, team work, and specific accomplishments. Expertise in innate and adaptive immunity and the development of small molecules and biologics as therapeutic agents from idea to clinic. Published over 43 manuscripts, 3 book chapters, and 3 reviews and gave over 54 presentations at national and international meetings.

Key Areas of Research
Immune based mechanisms of disease, immune modulation, antibody based therapies, T cell immunology, adaptive and innate immune mechanisms, chemokines, Toll-like receptors, cancer immunotherapy